N. B. Zharkova

mGlu2/3 Agonists – a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial

S. Mosolov, F. Martényi, L. Bardenstein, 2011, Neuroscience and Behavioral Physiology.

[The use of mGlu2/3 receptors as a new approach to treat schizophrenia: results of a randomized double-blind trial].

S. Mosolov, F. Martényi, A. Avedisova, 2010, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.